ID-Past Residents

Past Residents






Resident Year Project Position(s) After Residency
Elizabeth Sabo, PharmD, BCPS 2008-9 The impact of reporting extended spectrum beta-lactamase production on practitioner antimicrobial selection in Klebsiella bacteremia

Clinical Pharmacist, Infectious Diseases - Christiana Hospital, Clinical Pharmacist, Infectious Diseases - Pennsylvania Hospital
Clinical Coordinator, Pennsylvania Hospital

Jenna Ferrara, PharmD, BCPS 2009-10 The role of empiric therapy on outcomes in Gram-negative bacteremia

Clinical Pharmacist, Infectious Diseases - University of Pittsburgh Health System,
Assistant Professor, PCOM School of Pharmacy
Clinical Pharmacist, Emory Healthcare
Medical Science Liaison, AbbVie

Thy Le, PharmD, BCPS (AQID) 2010-11 Impact of the time to appropriate therapy on outcomes in candidemia

Clinical Pharmacist, Infectious Diseases - Coney Island Hospital
Coordinator of Infectious Diseases Pharmacotherapy - The Brooklyn Hospital Center
Director, Clinical Development and Optimization - Accelerate Diagnostics

Safia Kuriakose, PharmD, BCPS 2011-12 Case-case-control study of patients with carbapenem-resistant and third-generation cephalosporin-resistant Klebsiella pneumoniae bacteremia

Clinical Pharmacist, Infectious Diseases - St. Joseph’s Medical Center
Clinical Pharmacist - National Institute of Allergy and Infectious Diseases

Kimberly Miller, PharmD, BCPS 2012-13 Characteristics and cultures of patients with healthcare-associated pneumonia

Clinical Assistant Professor - Temple University School of Pharmacy
Medical Science Liaison- Allergan
Clinical Assistant Professor - Wilkes

Adrienne Terico, PharmD, BCPS, BCIDP 2013-14 A comparison of patients with methicillin-susceptible Staphylococcus aureusbacteremia who receive empiric vancomycin compared with those who receive a regimen containing an active beta-lactam Clinical Pharmacist, Infectious Diseases - Jefferson ARIA
Jessica Gallagher, PharmD, BCPS 2014-15 An evaluation of the effectiveness of double-carbapenem-based therapy for carbapenem-resistant Klebsiella pneumoniaeinfections.

Clinical Pharmacist, Infectious Diseases - Virtua Health


Clinical Pharmacy Specialist, Infectious Diseases - Lankenau Medical Center

Madeline King, PharmD, BCPS, BCIDP 2015-16 Ceftazidime/avibactam for carbapenem-resistant Enterobacteriaceaeinfections: a multicenter experience Assistant Professor - University of the Sciences
Alexandra Hanretty, PharmD 2016-17 A comparison of nephrotoxicity rates between polymyxin-containing regimens and beta-lactam-based regimens for multidrug resistant Gram-negative rod infections Clinical Pharmacist, Infectious Diseases - St. Christopher’s Hospital for Children
Ann Marie Porreca, PharmD, BCPS, BCIDP 2017-18 An assessment of the impact of MALDI-TOF without additional antimicrobial stewardship support. Clinical Pharmacist, Infectious Diseases - St. Luke’s Medical Center
Maria Heaney, PharmD 2018-19 A comparison of treatment patterns of coagulase-negative staphylococcal positive blood cultures before and after instituting MALDI-TOF Current resident